Sphere 3D Corp. (NASDAQ:ANY – Get Free Report) CEO Patricia Trompeter sold 20,000 shares of the firm’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $1.31, for a total value of $26,200.00. Following the completion of the sale, the chief executive officer now directly owns 597,187 shares of the company’s stock, valued at approximately $782,314.97. This represents a 3.24 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.
Patricia Trompeter also recently made the following trade(s):
- On Thursday, December 12th, Patricia Trompeter sold 10,000 shares of Sphere 3D stock. The stock was sold at an average price of $1.27, for a total value of $12,700.00.
Sphere 3D Stock Down 1.6 %
Shares of NASDAQ:ANY opened at $1.22 on Friday. Sphere 3D Corp. has a 52-week low of $0.67 and a 52-week high of $4.09. The stock has a market cap of $25.91 million, a price-to-earnings ratio of -1.52 and a beta of 2.91. The business has a 50-day moving average price of $1.22 and a 200-day moving average price of $1.07.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
ANY has been the subject of several recent analyst reports. StockNews.com downgraded Sphere 3D from a “hold” rating to a “sell” rating in a report on Tuesday, November 12th. HC Wainwright reissued a “buy” rating and issued a $3.00 price target on shares of Sphere 3D in a report on Monday, November 18th.
Get Our Latest Stock Report on ANY
About Sphere 3D
Sphere 3D Corp. engages in the bitcoin mining business. It is involved with digital asset mining pool operators to provide computing power to the mining pools. The company is based in Stamford, Connecticut.
Further Reading
- Five stocks we like better than Sphere 3D
- What is the Dogs of the Dow Strategy? Overview and Examples
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Health Care Stocks Explained: Why You Might Want to Invest
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Insider Trades May Not Tell You What You Think
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Sphere 3D Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sphere 3D and related companies with MarketBeat.com's FREE daily email newsletter.